Asset Details
Do you wish to reserve the book?
Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients : a randomized clinical trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients : a randomized clinical trial
Do you wish to request the book?
Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients : a randomized clinical trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients : a randomized clinical trial
2015
Overview
To compare the efficacy of gabapentin and levodopa-c (Levodopa / Carbidopa) in reducing restless leg syndrome (RLS) symptoms and sleep problems in hemodialysis patients with RLS in a four-week randomized clinical trial. The diagnosis of RLS was made using the criteria of the International Restless Legs Study Group. Each subject completed three questionnaires : IRLS questionnaire, Pittsburgh Sleep Quality Index and Epworth sleepiness scale. After four weeks of washout period for previous treatments for RLS, subjects were randomly assigned to four weeks of gabapentin (200 mg) or levodopa-c (110 mg). After four weeks of therapy, the questionnaires administered at the outset of the study were re-administered. Both drugs were found effective for the management of RLS. But, the effect of gabapentin was more significant. Gabapentin significantly improved the IRLS total score (change from baseline to post-treatment ≈–17) compared with levodopa-c (change from baseline to post-treatment ≈–13) (P : 0.016). Regarding sleep parameters, levodopa improved sleep quality, sleep latency and sleep duration (P < 0.0001). Gabapentin was also effective with respect to sleep parameters (P < 0.0001). Our study shows that gabapentin is a safe effective therapy for RLS among hemodialysis patients. This medication may be considered as an alternative or additive treatment to current therapeutic remedies for hemodialysis patients with RLS.
Publisher
Saudi Center for Organ Transplantation,Medknow Publications and Media Pvt. Ltd,Medknow Publications & Media Pvt. Ltd,Wolters Kluwer Medknow Publications
Subject
/ Aged
/ Cyclohexanecarboxylic Acids - therapeutic use
/ Dopa
/ gamma-Aminobutyric Acid - therapeutic use
/ Humans
/ Iran
/ Male
/ Motor Activity - drug effects
/ Patients
/ Renal Dialysis - adverse effects
/ Restless Legs Syndrome - diagnosis
/ Restless Legs Syndrome - drug therapy
/ Restless Legs Syndrome - etiology
/ Restless Legs Syndrome - physiopathology
/ المرضى
/ دوبا
